Structure-Based Development of Pyridoxal Propionate Derivatives as Specific Inhibitors of Cathepsin K in Vitro and in Vivo
- 27 January 2000
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 267 (3), 850-854
- https://doi.org/10.1006/bbrc.1999.1953
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Crystal structure of human cathepsin K complexed with a potent inhibitorNature Structural & Molecular Biology, 1997
- Proteolytic Activity of Human Osteoclast Cathepsin KJournal of Biological Chemistry, 1996
- Folding and Activation of Human Procathepsin S from Inclusion Bodies Produced in Escherichia coliEuropean Journal of Biochemistry, 1996
- Crystal structure of cathepsin B inhibited with CA030 at 2.0-.ANG. resolution: A basis for the design of specific epoxysuccinyl inhibitorsBiochemistry, 1995
- Molecular Cloning of Human cDNA for Cathepsin K: Novel Cysteine Proteinase Predominantly Expressed in BoneBiochemical and Biophysical Research Communications, 1995
- Purification and characterization of cathepsin J from rat liverEuropean Journal of Biochemistry, 1992
- Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivoFEBS Letters, 1991
- Amino acid sequence of rat liver cathepsin LFEBS Letters, 1988
- Molecular cloning and sequencing of cDNA for rat cathepsin LFEBS Letters, 1987
- 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.JCI Insight, 1987